BR9407507A - Proteina plasmídeo de co-transfecção para co-transfecção com dna viral veiculo recombinante vivo vacina contra coronavirus e processos para preparar uma molécula de dna e uma cacina contra coronavirus e fipv para proteger um mamifero de uma infecção por coronavirus e um felino de fipv - Google Patents

Proteina plasmídeo de co-transfecção para co-transfecção com dna viral veiculo recombinante vivo vacina contra coronavirus e processos para preparar uma molécula de dna e uma cacina contra coronavirus e fipv para proteger um mamifero de uma infecção por coronavirus e um felino de fipv

Info

Publication number
BR9407507A
BR9407507A BR9407507A BR9407507A BR9407507A BR 9407507 A BR9407507 A BR 9407507A BR 9407507 A BR9407507 A BR 9407507A BR 9407507 A BR9407507 A BR 9407507A BR 9407507 A BR9407507 A BR 9407507A
Authority
BR
Brazil
Prior art keywords
coronavirus
fipv
transfection
cacin
feline
Prior art date
Application number
BR9407507A
Other languages
English (en)
Portuguese (pt)
Inventor
Michel Bublot
Catherine De Wannemaeker
Didier Colau
Philippe Roux Salembien
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of BR9407507A publication Critical patent/BR9407507A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9407507A 1993-09-16 1994-09-07 Proteina plasmídeo de co-transfecção para co-transfecção com dna viral veiculo recombinante vivo vacina contra coronavirus e processos para preparar uma molécula de dna e uma cacina contra coronavirus e fipv para proteger um mamifero de uma infecção por coronavirus e um felino de fipv BR9407507A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9319212A GB2282601B (en) 1993-09-16 1993-09-16 Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
PCT/EP1994/002990 WO1995007987A2 (en) 1993-09-16 1994-09-07 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor

Publications (1)

Publication Number Publication Date
BR9407507A true BR9407507A (pt) 1997-01-07

Family

ID=10742112

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407507A BR9407507A (pt) 1993-09-16 1994-09-07 Proteina plasmídeo de co-transfecção para co-transfecção com dna viral veiculo recombinante vivo vacina contra coronavirus e processos para preparar uma molécula de dna e uma cacina contra coronavirus e fipv para proteger um mamifero de uma infecção por coronavirus e um felino de fipv

Country Status (10)

Country Link
EP (1) EP0720654A1 (ko)
JP (1) JPH09509562A (ko)
KR (1) KR960705047A (ko)
AU (1) AU7615894A (ko)
BR (1) BR9407507A (ko)
CA (1) CA2171869A1 (ko)
GB (2) GB2282601B (ko)
NO (1) NO961086L (ko)
WO (1) WO1995007987A2 (ko)
ZA (1) ZA946887B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724385B1 (fr) * 1994-08-29 1996-12-13 Rhone Merieux Vaccin de la peritonite infectieuse feline.
FR2741806B1 (fr) * 1995-11-30 1998-02-20 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
AU3650197A (en) * 1996-07-05 1998-02-02 Vanderbilt University Mutated antibody-dependent infection enhancing domains of hiv
FR2751223B1 (fr) * 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
CN1223605C (zh) * 2003-05-16 2005-10-19 中国科学院微生物研究所 抑制sars冠状病毒的多肽药物及其衍生物和其应用
CN113321714B (zh) * 2020-02-28 2022-12-09 深圳市亚辉龙生物科技股份有限公司 SARS-CoV-2的重组N蛋白及其制备与纯化方法
US20230331782A1 (en) * 2020-09-08 2023-10-19 The Trustees Of The University Of Pennsylvania Compositions and Methods for Reducing Risk of Vaccine-Enhanced Disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU576907B2 (en) * 1984-11-01 1988-09-08 American Home Products Corporation Oral vaccines comprising live recombinant adenoviruses
JPS63123385A (ja) * 1986-09-05 1988-05-27 デュファル・インテルナチオナル・レセールフ・ベー・ヴェー 新規抗原的活性蛋白質およびぺプチド、並びにネコ科感染性腹膜炎ウイルスワクチン
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
HUT54733A (en) * 1989-07-12 1991-03-28 Duphar Int Res Process for producing new, antigenically active proteins and peptides, as well as feline infectious peritonitis virus (fipv) vaccines
NZ240558A (en) * 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
WO1993023423A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Canine coronavirus s gene and uses therefor
JPH07504897A (ja) * 1992-02-18 1995-06-01 パーヘリオン　コーポレーション ネコ感染性腹膜炎ワクチンおよび調製方法
WO1993023422A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Compositions and methods for vaccination against coronaviruses

Also Published As

Publication number Publication date
WO1995007987A3 (en) 1995-06-22
GB9319212D0 (en) 1993-11-03
NO961086D0 (no) 1996-03-15
EP0720654A1 (en) 1996-07-10
ZA946887B (en) 1995-06-27
GB2282601A (en) 1995-04-12
GB9722558D0 (en) 1997-12-24
GB2316681A (en) 1998-03-04
CA2171869A1 (en) 1995-03-23
GB2316681B (en) 1998-04-15
GB2282601B (en) 1998-04-15
WO1995007987A2 (en) 1995-03-23
AU7615894A (en) 1995-04-03
NO961086L (no) 1996-05-09
JPH09509562A (ja) 1997-09-30
KR960705047A (ko) 1996-10-09

Similar Documents

Publication Publication Date Title
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
EP1009434A4 (en) HUMAN RECOMBINANT SERUM ALBUMIN STABILIZERS FOR LIVE VIRUS VACCINES
RU95115239A (ru) Аналог эритропоэтина
BR1100637A (pt) "vìrus de herpes de perus (hvt) recombinante, hvt recombinante, sequência de ácido nucléico, molécupara a preparação de um hvt recombinante, cultura uma vacina, processo para a preparação de uma composição de vacina, farmacêutica ou diagnóstica e anti-soro"
ATE348182T1 (de) Rekombinantes adeno-assoziiertes virus
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
AU4869299A (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
FR2620459B1 (fr) Virus recombinant de la vaccine
BR9407507A (pt) Proteina plasmídeo de co-transfecção para co-transfecção com dna viral veiculo recombinante vivo vacina contra coronavirus e processos para preparar uma molécula de dna e uma cacina contra coronavirus e fipv para proteger um mamifero de uma infecção por coronavirus e um felino de fipv
AU2328397A (en) Recombinant live feline immunodeficiency virus and proviral dna vaccines
SG55095A1 (en) Viruses and their use as a vaccine against feline infectious peritonitis virus disease
DE69934583D1 (de) Nukleinsäure-impfstoffe zur verhinderung der flaviviren-infektion
EP1100545A4 (en) REGULATED EXPRESSION OF RECOMBINANT PROTEINS USING RNA VIRUSES
WO1997003187A3 (en) Marek's disease virus genes and their use in vaccines for protection against marek's disease
CA2198743A1 (en) Feline infectious peritonitis vaccine
ES2132330T3 (es) Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino.
FR2756491B1 (fr) Composition transfectante utile en therapie genique associan t a un virus recombinant incorporant un acide nucleique exog ene, un agent de transfection non viral et non plasmidique
BR9801992A (pt) Processos para a preparação de vìrus da doença de marek usando linhas celulares contìnuas de mamìfero.
WO1988000973A1 (en) Recombinant plasmid dnas, coding for synthesis of polypeptide substances for a vaccine against hepatitis a
DE69738969D1 (de) Verfahren zur expression und herstellung des rekombinanten proteins gp90 der glykoproteinhülle des infektiösen pferdeanämievirus eiav
NZ331889A (en) Trypanosomatids histones for use as an antigen against trypanosomatic infection, including diagnostic tests, pharmaceutical compositions and vaccines of these antigens
AU7276198A (en) Live virus vaccines to protect primates from hiv-1 infection and disease
AU6268199A (en) Live virus vaccines to protect primates from hiv-1 infection and disease
BR9102369A (pt) Bioterapia para doencas veterinarias,anemia infecciosa equina,seudoraiva,linfadenite caseosa dos caprinos,metodo de obtencao dointerferon alfa-2b recombinante humano,para uso veterianrio

Legal Events

Date Code Title Description
PC Transfer

Free format text: DIMMINACO AG/SA/LTD (CH)

EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal